| Acutaas Chemicals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543349 |
NSE Symbol : ACUTAAS |
P/E(TTM) : 55.77 |
|
ISIN Demat : INE00FF01025 |
Div & Yield% : 0.08 |
EPS(TTM) : 35.66 |
|
Book Value(₹) : 173.03 |
Market Cap(₹Cr) : 16,281.30 |
Face Value(₹) : 5.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 390.86 | 305.19 | 205.97 | 304.16 | 270.94 | 243.59 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 390.86 | 305.19 | 205.97 | 304.16 | 270.94 | 243.59 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 6.34 | 8.97 | 16.02 | 5.69 | 2.17 | 8.58 |
| Total Income | 397.20 | 314.16 | 221.99 | 309.86 | 273.11 | 252.17 |
| Total Expenditure | 236.66 | 208.59 | 154.98 | 220.10 | 204.29 | 195.46 |
| PBIDT | 160.54 | 105.58 | 67.01 | 89.75 | 68.82 | 56.71 |
| Interest | 0.81 | 0.57 | 0.62 | 0.38 | 0.61 | 0.49 |
| PBDT | 159.72 | 105.00 | 66.39 | 89.37 | 68.21 | 56.22 |
| Depreciation | 9.02 | 7.72 | 7.46 | 6.56 | 5.67 | 6.20 |
| Tax | 36.36 | 19.35 | 12.73 | 15.23 | 16.27 | 11.85 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.78 | 5.04 | 1.55 | 4.74 | 0.97 | 0.49 |
| Reported Profit After Tax | 111.57 | 72.89 | 44.65 | 62.85 | 45.31 | 37.68 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 111.57 | 72.89 | 44.65 | 62.85 | 45.31 | 37.68 |
| EPS (Unit Curr.) | 13.63 | 8.90 | 5.45 | 7.84 | 11.31 | 9.41 |
| EPS (Adj) (Unit Curr.) | 13.63 | 8.90 | 5.45 | 3.92 | 5.66 | 4.71 |
| Calculated EPS (Unit Curr.) | 13.63 | 8.90 | 5.45 | 7.68 | 11.07 | 9.21 |
| Calculated EPS (Adj) (Unit Curr.) | 13.63 | 8.90 | 5.45 | 3.84 | 5.54 | 4.61 |
| Calculated EPS (Ann.) (Unit Curr.) | 54.51 | 35.61 | 21.81 | 30.71 | 44.27 | 36.82 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 54.51 | 35.61 | 21.81 | 15.36 | 22.14 | 18.41 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 40.94 | 40.94 | 40.93 | 40.93 | 40.93 | 40.93 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 41.07 | 34.59 | 32.53 | 29.51 | 25.40 | 23.28 |
| PBDTM(%) | 40.86 | 34.40 | 32.23 | 29.38 | 25.18 | 23.08 |
| PATM(%) | 28.54 | 23.88 | 21.68 | 20.66 | 16.72 | 15.47 |